NCT05547490View on ClinicalTrials.gov

A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

CompletedOBSERVATIONAL
Enrollment

3,506

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

April 28, 2023

Study Completion Date

April 28, 2023

Conditions
Psoriasis
Trial Locations (2)

100050

Local Institution - 0002, Beijing

210042

Local Institution - 0001, Nanjing

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05547490 - A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter